Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14

Deprecated: Function jetpack_form_register_pattern is deprecated since version jetpack-13.4! Use Automattic\Jetpack\Forms\ContactForm\Util::register_pattern instead. in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 6078
Cancer care major HCG files IPO papers - The Pharma Times | Pharma & Health Care News Portal

Cancer care major HCG files IPO papers

New Delhi, August 10, 2015: Healthcare Global Enterprises Ltd (HCG), a cancer care network operator, has filed draft papers with capital markets regulator Sebi to float an initial public offer (IPO).

With this, the total number of companies approaching Securities and Exchange Board of India (Sebi) since the beginning of 2015 has reached 24.

According to Draft Red Herring Prospectus (DRHP) filed with Sebi, HCG’s issue consists of a public offer of up to 3.11 crore equity shares — a fresh issue of up to 1.16 crore shares and an offer for sale of up to 1.95 crorescrips by existing stakeholders.

The offer constitutes 36.83 per cent of the company’s post offer paid-up equity share capital.

The proceeds of the issue would be used for purchase of medical equipment, investment in IT software, services and hardware, payment of debt and for general corporate purposes.

The Bengaluru-based firm operates one of the largest cancer care networks in the country under the brand name ‘HCG’.Currently, HCG has 15 comprehensive cancer centres.

After a quiet 2014, IPO market is humming again as 24 companies have filed draft documents with Sebi to launch IPOs this year, while some others including GVK Airport are in the process to file initial papers.

The companies that approached Sebi since January include Cafe Coffee Day, Matrix Cellular, IndiGo, RBL Bank, Paranjape Schemes (Construction) and Numero Uno Clothing.

The flurry of activities also come at a time when Sebi has announced a slew of fresh reforms in the IPO space, including halving the listing period to six days.

So far in 2015, eight companies have launched IPOs and have collectively raised nearly 4,000 crore, while the public offer of biotechnology major Biocon’s research arm Syngene International is currently underway.

In comparison, a total of six IPOs had hit the market in the entire 2014 and together garnered just Rs 1,528 crore.
CCI Newswire

The Pharma Times News Bureau

Recent Posts

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

7 hours ago

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

1 week ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

1 week ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago